Skip to main content
. 2014 Nov 28;6(1):494–509. doi: 10.18632/oncotarget.2674

Figure 1. Low miR-125a-5p expression correlates with tumor size and poor survival in breast cancer patients.

Figure 1

(A) The average tumor size (mm in diameter) of the high miR-125a-5p level subgroup (n = 142) and the low miR-125a-5p level subgroup (n = 158). (B–D) Curves show the overall survival rates (B) and survival of patients with negative (C) or positive (D) lymph nodes in patients with high (solid line) versus low (dotted line) miR-125a-5p levels. (E) The multivariate Cox regression analysis of survival with the clinicopathological parameters and the miR-125a-5p expression.